Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CardieX
Sydney, New South Wales, Australiacardiex.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Other
01
Overview
CardieX has developed and commercialized the SphygmoCor platform—a suite of FDA-cleared noninvasive devices for measuring central blood pressures and arterial stiffness. Their technologies are deployed globally in clinical practice, research institutions, and clinical trials to assess cardiovascular risk. The company’s latest products include the CONNEQT Pulse digital vascular biomarker monitor. Over 2,400 peer-reviewed publications support their core technology[1][3].
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceDigital biomarker platform
- Industry
- Physiological Monitoring
02
Partnerships
Blumio Inc. acquisition—advanced wearable sensor tech integration[5]
Beyond the preview
Go deeper on CardieX.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CardieX.